CIK 0001566044 · Non-accelerated filer<br>Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453757789
- Phone
- (203) 433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-29 | Payton Lori Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +99,827 | 99,827 | ||
| 2026-10-29 | Alford Rachael Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +89,844 | 89,844 | ||
| 2026-10-29 | Frey Rebecca Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +465,857 | 465,857 | ||
| 2026-10-29 | Ryder Steven Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +113,137 | 113,137 | ||
| 2026-10-29 | Zeronda Tyler Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +156,115 | 156,115 | ||
| 2026-07-29 | RTW Fund Group GP, LLC 10% owner | Other disposition | −133,290 | 266,307 | ||
| 2026-07-29 | RTW Fund Group GP, LLC 10% owner | Other acquisition · Pre-Funded Warrants (Right to Buy) | +133,290 | 8,949,719 | ||
| 2026-07-27 | Ashiya Mona Director | Grant or award · Stock Option (Right to Buy) | +15,435 | 15,435 | ||
| 2026-07-27 | Zeronda Tyler Director | Grant or award · Stock Option (Right to Buy) | +185,798 | 185,798 | ||
| 2026-07-23 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −22,516 | $0.90 | $20K | 74,918 |
| 2026-07-23 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −22,516 | $0.90 | $20K | 95,918 |
| 2026-07-23 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −79,391 | $0.90 | $71K | 347,174 |
| 2026-07-23 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −15,405 | $0.90 | $14K | 95,944 |
| 2026-06-30 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,464 | $0.65 | $2K | 97,434 |
| 2026-06-30 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −3,464 | $0.65 | $2K | 118,434 |
| 2026-06-30 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −12,214 | $0.65 | $8K | 426,565 |
| 2026-06-30 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,370 | $0.65 | $2K | 111,349 |
| 2026-05-29 | Domzalski David PRESIDENT AND CEO | Grant or award | +30,791 | $0.31 | $10K | 438,779 |
| 2026-03-31 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −4,007 | $0.60 | $2K | 99,788 |
| 2026-03-31 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −4,007 | $0.60 | $2K | 121,898 |
Page 1 of 6 · 113 trades